Develop nano-robots to treat genetic diseases

Scientists at the California Institute of Technology in the United States have used nanotechnology to make robots that can travel in the blood to deliver appropriate therapeutic treatments for genetic diseases to tissues. sick in the human body.

The nanoparticles are covered with a specific protein that opens the door to molecules of various tissues.

This success opens up a new direction of treatment called gene interference (RNAi).

Large global pharmaceutical and biotech companies such as Alnylam, Merck, Pfizer, Novartis and Roche are looking for ways to use RNA to prevent genes that cause diseases like cancer, blindness or HIV / AIDS.

Lead researcher Mark Davis, professor of chemical technology, said that this was the first study of an effective mechanism of action against genetic diseases.

Once the nano-robots detect cancer cells and enter the cell's interior, it breaks off, releasing RNAs that block the cells from turning the cells into cancer cells.

Clinical trials for melanoma show that nanobots have found a way to get inside tumor cells and neutralize pathogenic genes.

The study will be published at the American College of Clinical Oncology Conference in June.